EUVIMEDObjevte EUVIMED
Systematische ÜbersichtMetaanalyse

Effects of Probiotic and Synbiotic Supplementation on Metabolic and Hepatic Outcomes in Children and Adolescents With Obesity, Including Those With Obesity‐Related Metabolic Dysfunction–Associated Steatotic Liver Disease: A Systematic Review and Meta‐Analysis

Effekte von Probiotika- und Synbiotika-Supplementierung auf metabolische und hepatische Endpunkte bei Kindern und Jugendlichen mit Adipositas, einschließlich adipositasassoziierter MASLD: systematische Übersicht und Metaanalyse

Pedram Pam iD, Mohammad Safari, Ali Hojati iD, Rasoul Zarrin, Amir Hossein Faghfouri iD

Journal of Paediatrics and Child Health · 2026-05 · 62 (5) · 678-696

DOI: 10.1111/jpc.70344 ↗

Auf einen Blick

13 RCTs mit 848 Kindern und Jugendlichen: Probiotika/Synbiotika senkten Gesamtcholesterin, LDL-C und ALT. Für BMI z-Score, Bauchumfang und Blutzucker zeigten sich keine signifikanten Verbesserungen.

Fragestellung

Welche Effekte haben Probiotika und Synbiotika auf metabolische und hepatische Endpunkte bei Kindern und Jugendlichen mit Adipositas oder MASLD?

Methode

Systematische Übersicht und Metaanalyse von RCTs; Suche in PubMed, Scopus und Web of Science bis September 2025; Risikobewertung mit Cochrane Risk of Bias und GRADE.

Ergebnisse

13 RCTs (n = 848). Gesamtcholesterin: WMD −6,40 mg/dL (95 %-KI −8,78 bis −4,01); LDL-C: WMD −2,68 mg/dL (95 %-KI −4,85 bis −0,50); ALT: WMD −6,15 U/L (95 %-KI −10,14 bis −2,16). HOMA-IR stieg: WMD 0,68 (95 %-KI 0,53 bis 0,83).

Einschränkungen

Substanzielle Heterogenität und begrenzte Evidenzqualität; die Evidenz war für die meisten anderen Messgrößen niedrig oder sehr niedrig.

Schlussfolgerung der Autor:innen

Trotz gemischter Ergebnisse deuten Probiotika und Synbiotika auf Nutzen bei einzelnen metabolischen Endpunkten hin; wegen der Glukosehomöostase ist Vorsicht geboten, und personalisierte Ansätze sollten erwogen werden.

Kernaussagen

  • Gesamtcholesterin, LDL-C und ALT sanken signifikant.
  • Kein signifikanter Effekt auf BMI z-Score, Bauchumfang, Triglyzeride, HDL-C oder Nüchternblutzucker.
  • HOMA-IR nahm signifikant zu.

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

At a glance

Systematische Übersicht in Journal of Paediatrics and Child Health, published online on 2026-04-10. Written by Pedram Pam and 4 co-authors. Institution: Food and Beverages Safety Research Center, Urmia University of Medical Sciences, Urmia, Iran. Major MEDLINE topics: Probiotics, Synbiotics, Fatty Liver, Pediatric Obesity. Cited 1 times so far (Crossref); 56 references.

Auf einen BlickAbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Aim

This systematic review and meta‐analysis evaluated the effects of probiotic and synbiotic supplementation on metabolic and hepatic outcomes in children and adolescents with obesity, including those with obesity‐related metabolic dysfunction–associated steatotic liver disease (MASLD).

Methods

A comprehensive literature search of PubMed, Scopus and Web of Science was conducted up to September 2025. Randomised controlled trials (RCTs) investigating probiotic or synbiotic supplementation in paediatric populations with obesity or MASLD were included. Data were pooled using a random‐effects model, and the Cochrane Risk of Bias tool and GRADE framework were used for quality assessment.

Results

Thirteen RCTs ( n = 848) were included. Pooled analyses demonstrated significant reductions in total cholesterol (WMD: −6.40 mg/dL, 95% CI: −8.78, −4.01), LDL‐C (WMD: −2.68 mg/dL, 95% CI: −4.85, −0.50) and alanine aminotransferase (ALT) (WMD: −6.15 U/L, 95% CI: −10.14, −2.16). No significant improvements were observed in BMI z ‐score, waist circumference, triglycerides, HDL‐C or fasting blood sugar. A significant increase in HOMA‐IR was found (WMD: 0.68, 95% CI: 0.53, 0.83). Evidence certainty was high for lipid outcomes but low or very low for most other measures.

Conclusions

Despite these mixed results, substantial heterogeneity and limited evidence quality underscore the need for well‐designed, strain‐specific trials. Probiotic and synbiotic supplementation show promise for specific metabolic outcomes in paediatric populations, though caution is warranted regarding glucose homeostasis, and personalised approaches should be considered in clinical practice.

Subjects

MeSH terms (MEDLINE)

ProbioticsSynbioticsFatty LiverPediatric ObesityHumansChildAdolescentDietary SupplementsRandomized Controlled Trials as Topic

Author keywords

MASLDchildhood obesitylipid profileliver enzymesprobioticssynbiotics

Authors and institutions

  • Food and Beverages Safety Research Center, Urmia University of Medical Sciences, Urmia, Iran.
  • Student Research Committee, Urmia University of Medical Sciences, Urmia, Iran.
  • Department of Nutrition, School of Medicine, Urmia University of Medical Sciences, Urmia, Iran.
  • Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Faculty of Nutrition and Food Sciences, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Maternal and Childhood Obesity Research Center, Urmia University of Medical Sciences, Urmia, Iran.

ORCID profiles: Pedram Pam, Ali Hojati, Amir Hossein Faghfouri

Cite

APA

Pam, P., Safari, M., Hojati, A., Zarrin, R., & Faghfouri, A. H. (2026). Effects of Probiotic and Synbiotic Supplementation on Metabolic and Hepatic Outcomes in Children and Adolescents With Obesity, Including Those With Obesity‐Related Metabolic Dysfunction–Associated Steatotic Liver Disease: A Systematic Review and Meta‐Analysis. Journal of Paediatrics and Child Health, 62(5), 678-696. https://doi.org/10.1111/jpc.70344

Vancouver

Pam P, Safari M, Hojati A, Zarrin R, Faghfouri AH. Effects of Probiotic and Synbiotic Supplementation on Metabolic and Hepatic Outcomes in Children and Adolescents With Obesity, Including Those With Obesity‐Related Metabolic Dysfunction–Associated Steatotic Liver Disease: A Systematic Review and Meta‐Analysis. Journal of Paediatrics and Child Health. 2026;62(5):678-696. doi:10.1111/jpc.70344

BibTeX
@article{Pam2026,
  author = {Pam, Pedram and Safari, Mohammad and Hojati, Ali and Zarrin, Rasoul and Faghfouri, Amir Hossein},
  title = {Effects of Probiotic and Synbiotic Supplementation on Metabolic and Hepatic Outcomes in Children and Adolescents With Obesity, Including Those With Obesity‐Related Metabolic Dysfunction–Associated Steatotic Liver Disease: A Systematic Review and Meta‐Analysis},
  journal = {Journal of Paediatrics and Child Health},
  year = {2026},
  volume = {62},
  number = {5},
  pages = {678--696},
  doi = {10.1111/jpc.70344}
}
Start for free →